Variant report

Variant	rs528997822
Chromosome Location	chr2:20349424-20349425
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr2:20344027..20347003-chr2:20348055..20350773,2	MCF-7	breast:
2	chr2:20348708..20350605-chr2:20350801..20352836,2	MCF-7	breast:
3	chr2:20343488..20346809-chr2:20347899..20350701,3	MCF-7	breast:
4	chr2:20348330..20350992-chr2:20378144..20381464,4	MCF-7	breast:

Extended variants
information (count: 10 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:10 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1009521	chr2:20310479-20388959	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
2	nsv1012841	chr2:20328894-20415168	Enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
3	nsv1012055	chr2:20336237-20356606	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	inside rSNPs	diseases
4	nsv1004083	chr2:20336237-20388138	Weak transcription Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
5	nsv1000323	chr2:20336237-20419923	Enhancers Weak transcription Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
6	nsv1004947	chr2:20342264-20388138	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
7	nsv1005923	chr2:20344028-20369781	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases
8	nsv581156	chr2:20346312-20356944	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	inside rSNPs	diseases
9	nsv997958	chr2:20349343-20386339	Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
10	nsv1005524	chr2:20349343-20388138	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:71 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:20332200-20364400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:20345600-20349800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr2:20345600-20356600	Weak transcription	Liver	Liver
4	chr2:20346000-20355600	Weak transcription	Esophagus	oesophagus
5	chr2:20346800-20352800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr2:20348000-20349600	Enhancers	Brain Germinal Matrix	brain
7	chr2:20348000-20349800	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr2:20348000-20349800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr2:20348000-20351200	Enhancers	HUES64 Cell Line	embryonic stem cell
10	chr2:20348000-20351400	Enhancers	HSMM	muscle
11	chr2:20348200-20349600	Enhancers	Fetal Kidney	kidney
12	chr2:20348200-20349800	Enhancers	iPS-15b Cell Line	embryonic stem cell
13	chr2:20348200-20350000	Enhancers	HUES6 Cell Line	embryonic stem cell
14	chr2:20348200-20351200	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr2:20348400-20349600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
16	chr2:20348400-20349600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr2:20348400-20349600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr2:20348400-20349600	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr2:20348400-20349600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
20	chr2:20348400-20349600	Enhancers	K562	blood
21	chr2:20348400-20349600	Flanking Active TSS	NH-A	brain
22	chr2:20348400-20349800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr2:20348400-20349800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
24	chr2:20348400-20350000	Enhancers	HMEC	breast
25	chr2:20348400-20350000	Enhancers	NHLF	lung
26	chr2:20348400-20350400	Enhancers	H1 Cell Line	embryonic stem cell
27	chr2:20348400-20351200	Enhancers	Fetal Lung	lung
28	chr2:20348400-20351400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr2:20348600-20349600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
30	chr2:20348600-20349600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
31	chr2:20348600-20349600	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr2:20348600-20349600	Enhancers	Adipose Nuclei	Adipose
33	chr2:20348600-20349600	Enhancers	A549	lung
34	chr2:20348600-20349600	Enhancers	Hela-S3	cervix
35	chr2:20348600-20349800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr2:20348600-20349800	Enhancers	Duodenum Mucosa	Duodenum
37	chr2:20348600-20349800	Enhancers	Placenta	Placenta
38	chr2:20348600-20349800	Flanking Active TSS	Osteobl	bone
39	chr2:20348600-20350000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr2:20348600-20350000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr2:20348600-20351000	Enhancers	H9 Cell Line	embryonic stem cell
42	chr2:20348600-20351200	Enhancers	Fetal Brain Female	brain
43	chr2:20348600-20351200	Enhancers	Fetal Muscle Leg	muscle
44	chr2:20348800-20349600	Enhancers	NHEK	skin
45	chr2:20348800-20349800	Enhancers	Pancreas	Pancrea
46	chr2:20348800-20351800	Enhancers	Fetal Brain Male	brain
47	chr2:20349000-20349800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
48	chr2:20349000-20349800	Flanking Active TSS	HSMMtube	muscle
49	chr2:20349000-20353000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
50	chr2:20349200-20349600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links